News - Generics


Current filters:


Popular Filters

1226 to 1238 of 1238 results

US FTC finds 60% rise in pharma pay-for-delay deals; flawed understanding says GPhA


Pharmaceutical companies in the USA struck an unprecedented number of deals in fiscal year 2010 in which…

GenericsLicensingNorth AmericaPharmaceutical

Teva to buy Japanese generic drugmaker Taiyo?


According to Japan’s leading financial newspaper, The Nikkei, Israeli generics drug giant Teva Pharmaceutical…

Asia-PacificGenericsMergers & AcquisitionsTaiyo PharmaTeva Pharmaceutical Industries

Mylan's 1st-qtr 2011 adjusted diluted EPS up 22%, in line with forecasts


US generics group Mylan (Nasdaq: MYL) reported that total revenues for the quarter ended March 31, 2011…

FinancialGenericsMylan Laboratories

European Commission opens investigation against Cephalon and Teva


The European Commission has opened a formal antitrust investigation to assess whether an agreement between…

CephalonEuropeGenericsLegalTeva Pharmaceutical Industries

Hikma must sell two drugs as condition of Baxter Healthcare acquisition, says US antitrust body


The USA’s Federal Trade Commission will require Jordan-based drugmaker Hikma Pharmaceuticals (LSE:…

Baxter HealthcareGenericsHikma PharmaceuticalsLegalMergers & Acquisitions

Generic drug sales in Brazil leapt 53% in 2010; double-digit growth forecast the next two years


In Brazil, sales last year of generic drugs - which are nearly identical reproductions of off-patent…

GenericsMarkets & MarketingPatentsSouth America

Watson 1st-qtr 2011 net revenue Increases 2.3% to $877 million


USA-based generics and specialty drugmaker Watson Pharmaceuticals (NYSE: WPI) reported net revenue of…

FinancialGenericsPharmaceuticalWatson Pharmaceuticals

AstraZeneca and Pozen sue Dr Reddy’s over Vimovo patent


Anglo-Swedish drug major AstraZeneca (LSE: AZN and USA-based Pozen (Nasdaq; POZN) have filed a law suit…

Anti-Arthritics/RheumaticsAstraZenecaDr Reddy's LaboratoriesGenericsLegalNorth AmericaPatentsPharmaceuticalPozenVimovo

Hospira’s first-quarter 2011 results beat forecasts, helped by generic Taxotere


Specialty drugmaker Hospira (NYSE: HSP) yesterday reported results for the first quarter ended March…


Alapis enters MoU with China's CSPC Pharma on areas of collaboration


Greek drugmaker Alapis SA (APSHF: PK) has signed a memorandum of understanding (MoU) with one of China's…

AlapisCSPC PharmaceuticalGenericsLicensing

1226 to 1238 of 1238 results

Back to top